GuangYuYuan Chinese Herbal Medicine Co., Ltd. (SHA:600771)

SHA:600771 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	361.3	296.75	116.67	259.97	246.4	145.15
Cash & Short-Term Investments	411.43	296.75	116.67	259.97	246.4	145.15
Cash Growth	77.85%	154.35%	-55.12%	5.51%	69.76%	-63.13%
Accounts Receivable	555.85	511.2	439.13	830.73	1,033	1,460
Other Receivables	32.54	11.97	10.83	1.66	56.53	143.34
Receivables	588.39	523.17	449.96	832.39	1,089	1,603
Inventory	689.14	749.98	766.95	569.53	415.04	352.9
Other Current Assets	20.67	13.69	33.83	20.33	13.15	24.07
Total Current Assets	1,710	1,584	1,367	1,682	1,764	2,125
Property, Plant & Equipment	603.57	613.64	663.48	707.24	710.26	738.37
Long-Term Investments	13.29	15.17	16.57	25.89	32.89	53.89
Other Intangible Assets	85.63	86.94	96.09	93.75	98.54	96.13
Long-Term Deferred Tax Assets	94.05	95.35	95.93	91.69	73.69	61.29
Long-Term Deferred Charges	3	3.16	3.79	4.34	6.16	12.37
Other Long-Term Assets	36.57	38.94	32.61	23.28	15.32	15.37
Total Assets	2,546	2,437	2,276	2,628	2,701	3,102

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	74.89	93.3	60.27	56.41	263.87	489.08
Accrued Expenses	35.54	368.44	373.13	508.35	419.04	54.25
Short-Term Debt	8	8	19.95	56.06	165	245.86
Current Portion of Long-Term Debt	-	-	-	189.86	62.2	12
Current Portion of Leases	-	8.62	8.19	6.33	1.93	-
Current Income Taxes Payable	43.93	9.85	2.17	0.71	-	1.42
Current Unearned Revenue	110.51	125.88	50.83	69.02	38.78	20.25
Other Current Liabilities	505.31	122.37	119.16	156.82	106.49	50.62
Total Current Liabilities	778.18	736.46	633.7	1,044	1,057	873.49
Long-Term Debt	-	-	-	-	197.6	70
Long-Term Leases	23.13	25.07	33.79	39.11	6.2	-
Long-Term Unearned Revenue	19.48	19.76	15.27	15.1	13.63	15.35
Long-Term Deferred Tax Liabilities	2.48	2.48	2.4	13.51	2.7	2.81
Other Long-Term Liabilities	-	-	-	9.27	-	-
Total Liabilities	823.26	783.77	685.17	1,121	1,277	961.65

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	489.49	489.49	489.49	489.49	489.49	492
Additional Paid-In Capital	1,588	1,588	1,588	1,588	1,588	1,637
Retained Earnings	-374.82	-441.56	-504.61	-579.06	-669.14	17.17
Treasury Stock	-	-	-	-	-	-51.22
Comprehensive Income & Other	-3.48	-3.48	-3.29	-2.52	5.55	4.53
Total Common Equity	1,699	1,633	1,570	1,496	1,414	2,099
Minority Interest	23.06	20.35	20.9	11.74	9.25	41.42
Shareholders' Equity	1,722	1,653	1,591	1,508	1,423	2,141
Total Liabilities & Equity	2,546	2,437	2,276	2,628	2,701	3,102

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	31.13	41.69	61.94	291.36	432.93	327.86
Net Cash (Debt)	380.3	255.06	54.74	-31.39	-186.54	-182.71
Net Cash Growth	128.97%	365.97%	-	-	-	-
Net Cash Per Share	0.78	0.53	0.10	-0.06	-0.38	-0.37
Filing Date Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Total Common Shares Outstanding	489.49	489.49	489.49	489.49	489.49	489.49
Working Capital	931.44	847.13	733.71	638.67	706.65	1,252
Book Value Per Share	3.47	3.34	3.21	3.06	2.89	4.29
Tangible Book Value	1,614	1,546	1,474	1,402	1,316	2,003
Tangible Book Value Per Share	3.30	3.16	3.01	2.86	2.69	4.09
Buildings	-	712.62	724.01	728	740.85	744.18
Machinery	-	168.47	165.14	161.58	162.29	162.16
Construction In Progress	-	0.42	-	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 20, 2026

Data Sources Report a data error